Patient survival factors in paranasal sinus mucormycosis
- 1 April 1980
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 90 (4) , 635-648
- https://doi.org/10.1288/00005537-198004000-00010
Abstract
Analysis of 170 cases of paranasal sinus mucormycosis collected from the literature and 9 cases of our own revealed a 50% mortality for this disease. When analyzed according to decade, survival has increased to 70% in the cases reported from 1970‐1979. There were no significant differences between the survivors and the fatalities when evaluated according to age, sex, laterality, or radiographic findings. There was a markedly poorer prognosis for those patients with hemiplegia, facial necrosis, and nasal deformity. The underlying disease was an important determinant of survival: 75% of patients with no systemic disease, 60% of diabetics, and 20% of patients with other disorders survived. Surgical debridement or radical resection and the use of amphotericin B significantly increased survival. Their combination further enhanced survival, especially in the diabetic.Keywords
This publication has 69 references indexed in Scilit:
- Acute Rhino-Orbito-Cerebral MucormycosisOphthalmologica, 1976
- Cerebral mucormycosis following open head traumaJournal of Neurosurgery, 1975
- Cerebral mucormycosis and renal aspergillosis in heroin addicts without endocarditisThe Lancet Healthy Longevity, 1973
- Rhinocerebral phycomycosis (mucorymycosis)The Laryngoscope, 1973
- Mucormycosis.British Journal of Ophthalmology, 1969
- Fungal infections complicating acute leukemiaJournal of Chronic Diseases, 1966
- Phycomycosis (Mucormycosis) of the Central Nervous SystemJournal of Neurosurgery, 1965
- Acute cerebral phycomycosis (mucormycosis)The Journal of Pediatrics, 1962
- MUCORMYCOSISThe Lancet Healthy Longevity, 1961
- Mucormycosis of the central nervous system associatedwith thrombosis of the internal carotid arteryThe Journal of Pediatrics, 1954